Researcher found that OIP5-AS1 expression was down-regulated in tissues affected by multiple myeloma (MM), and in MM cells, overexpression of OIP5-AS1 demonstrated anti-tumor potential (39). Here, OIP5 is linked to plasma cell myeloma.